COVID‐19 and favipiravir induce cutaneous adverse reactions: a difficulty in clinical dermatology practice
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Dermatology"
DOI: 10.1111/ced.15202
Abstract: There have been reports of skin rash developing in patients with COVID‐19 on favipiravir therapy, including a recent report in this journal. We report a patient who developed a maculopapular skin rash while taking favipiravir. read more here.
Keywords: covid favipiravir; adverse reactions; favipiravir induce; induce cutaneous ... See more keywords
Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19)
Sign Up to like & getrecommendations! Published in 2020 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.02017-20
Abstract: It is becoming increasingly clear that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), like most human viral infections, will require multiple drugs in combination to treat COVID-19 illness. In this issue of the Journal, Doi… read more here.
Keywords: treatment; covid favipiravir; infection; ambulatory ... See more keywords